Comment from Karo Pharma Aktiebolag's board of directors regarding the public offer from Karo Intressenter AB
Today, on 16 August 2022, Karo Intressenter AB[1] ("Karo Intressenter") announced a public cash offer to the shareholders in Karo Pharma Aktiebolag ("Karo Pharma") to acquire the shares in Karo Pharma not already held by Karo Intressenter at a price of SEK 60 per share (the "Offer"). For further information about the Offer, please refer to Karo Intressenter's press release . Karo Intressenter is expected to publish an offer document